Ir para o conteúdo principal

Inspire Medical Systems (NYSE: INSP) — Perfil da empresa, notícias e dados financeiros

Logo de Inspire Medical Systems
INSP Inspire Medical Systems
Inspire Medical Systems primary media
Perfil da empresa

Inspire Medical Systems

Inspire Medical Systems (NYSE:INSP) specializes in developing and marketing innovative medical solutions targeted towards the treatment of obstructive sleep apnea (OSA). With a core focus on improving patient quality of life, their flagship product is a minimally invasive implantable device that works inside the body to open key airway muscles during sleep, leveraging the body’s natural breathing process. Founded with the goal of offering alternative treatments to traditional CPAP machines, Inspire aims to lead in the field of sleep disorder therapies through continuous innovation and the expansion of their product line. At the heart of their objectives is a commitment to clinical excellence, patient satisfaction, and making a positive impact on the millions suffering from sleep-related breathing issues.

Resumo

Public USParticipação acionária
2007Ano de fundação
1011Funcionários
Minneapolis, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
Minneapolis, US

Produtos e/ou serviços de Inspire Medical Systems

  • Inspire Therapy, a fully integrated obstructive sleep apnea treatment using a small device to stimulate key airway muscles.
  • Patient remote, a tool for adjusting therapy settings and managing treatment.
  • Physician's remote, enabling doctors to assess and modify therapy parameters remotely.
  • Clinical research initiatives focused on advancing sleep apnea treatment knowledge and efficacy.
  • Educational resources for patients and healthcare professionals to improve understanding and management of sleep apnea.
  • Partnerships with medical institutions for the development and testing of sleep apnea treatment technologies.

equipe executiva do Inspire Medical Systems

  • Timothy P. HerbertFounder, Chairman, CEO & President
  • Bryan K. PhillipsSenior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
  • Carlton W. WeatherbyChief Strategy and Growth Officer
  • Matthew J. OsbergExecutive VP & CFO
  • Jason P. KellyChief Operations & Innovation Officer
  • Melissa J. MannChief People Officer
  • Ivan LubogoSVP of Strategic Sales
  • Andreas HenkeExecutive VP International & MD
  • Joseph E. SanderSenior Vice President of U.S. Sales
  • Megan RowekampDirector of Financial Reporting

Principais indicadores financeiros

Resultados divulgados pela Inspire Medical Systems, em USD.

Cap. de mercado
2,1 bi
Receita (TTM)
898,7 mi
P/L
15.7
LPA (diluído, TTM)
4.5
Dividend yield
—
Margem de lucro
15.0%
Receita e lucro anuais da Inspire Medical Systems
Fim do ano fiscalReceitaResultado operacionalLucro líquido
912 mi51 mi145,4 mi
802,8 mi36,1 mi53,5 mi
624,8 mi-40,3 mi-21,2 mi
407,9 mi-47,6 mi-44,9 mi